MIST
Milestone Pharmaceuticals Inc
NASDAQ: MIST · HEALTHCARE · BIOTECHNOLOGY
$1.80
-1.10% today
Updated 2026-04-30
Market cap
$218.86M
P/E ratio
—
P/S ratio
141.57x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$1 – $3
Volume
2.1M
Milestone Pharmaceuticals Inc (MIST) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-9.7%
Last 4 quarters
Revenue YoY growth
+1331.5%
Most recent quarter
EPS YoY growth
+21.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+14.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+29.7%
2026-03-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.15 | +6.3% | $1.01 | $1.31 | +29.7% |
| 2025-11-12 | $-0.12 | +25.0% | $1.91 | $1.90 | -0.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.16 | $-0.15 | +6.3% | $1.55M | +1331.5% |
| 2025-09-30 | $-0.16 | $-0.12 | +25.0% | — | — |
| 2025-06-30 | $-0.18 | $-0.20 | -11.1% | — | — |
| 2025-03-31 | $-0.20 | $-0.31 | -59.0% | — | — |
| 2024-12-31 | $-0.15 | $-0.19 | -26.7% | $108000.00 | -112.4% |
| 2024-09-30 | $-0.16 | $-0.14 | +10.9% | — | — |
| 2024-06-30 | $-0.19 | $-0.14 | +26.3% | — | — |
| 2024-03-31 | $-0.26 | $-0.21 | +19.2% | $-868002.00 | -186.8% |
| 2023-12-31 | $-0.31 | $-0.32 | -3.2% | $-868002.00 | — |
| 2023-09-30 | $-0.38 | $-0.35 | +7.9% | — | — |
| 2023-06-30 | $-0.39 | $-0.37 | +5.1% | — | — |
| 2023-03-31 | $-0.40 | $-0.35 | +12.5% | $1.00M | — |
Frequently asked questions
Has Milestone Pharmaceuticals Inc beaten earnings estimates?
Milestone Pharmaceuticals Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -9.7% over the last 4 quarters.
How does MIST stock react to earnings?
MIST stock has moved an average of +14.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Milestone Pharmaceuticals Inc's revenue growth rate?
Milestone Pharmaceuticals Inc reported year-over-year revenue growth of +1331.5% in its most recent quarter, with EPS growing +21.1% year-over-year.